Original Research

Published on 06 Jan 2023

Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27

in Pharmacology of Anti-Cancer Drugs

Pengfei Qiao
Zhentao Tian

Frontiers in Oncology

doi 10.3389/fonc.2022.1084884

1,756 views
8 citations

Review

Published on 05 Jan 2023

New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy

in Pharmacology of Anti-Cancer Drugs

Abdulrahman Theyab
Khalaf F. Alsharif
Khalid J. Alzahrani
Atif Abdulwahab A. Oyouni
Yousef MohammedRabaa Hawsawi
Mohammad Algahtani
Saad Alghamdi
Amal F. Alshammary

Frontiers in Oncology

doi 10.3389/fonc.2022.1026377

5,096 views
9 citations

Review

Published on 04 Jan 2023

Advances in research on the relationship between thymoquinone and pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

Zhanxue Zhao
Linxun Liu
Shuai Li
Xiaofan Hou
Jinyu Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1092020

6,820 views
8 citations

Review

Published on 04 Jan 2023

The function of natural compounds in important anticancer mechanisms

in Pharmacology of Anti-Cancer Drugs

Yang Nan
Hongchan Su
Bo Zhou
Shumin Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1049888

7,542 views
27 citations

Editorial

Published on 22 Dec 2022

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing

in Pharmacology of Anti-Cancer Drugs

Rajkumar Singh Kalra
Sandeep Singh
Anjana Munshi
Jitender Bariwal

Frontiers in Oncology

doi 10.3389/fonc.2022.1106610

958 views

Review

Published on 22 Dec 2022

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders

in Pharmacology of Anti-Cancer Drugs

Elsa Maitre
Jerome Paillassa
Xavier Troussard

Frontiers in Oncology

doi 10.3389/fonc.2022.1068981

4,657 views
8 citations

Mini Review

Published on 20 Dec 2022

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies

in Pharmacology of Anti-Cancer Drugs

Shenhe Jin
Ye Zhang
Fengping Zhou
Xiaochang Chen
Jianpeng Sheng
Jin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1091782

6,564 views
12 citations

Clinical Trial

Published on 20 Dec 2022

A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer

in Pharmacology of Anti-Cancer Drugs

Yinjuan Li
Lu Qi
Yu Wang
Yan Li
Chunpu Lei
Yingjuan Zhang
Xiaoqiang Cheng
Ju Liu
HaiHong Bai
Xia Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1070001

2,959 views
1 citation

Original Research

Published on 16 Dec 2022

siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro

in Pharmacology of Anti-Cancer Drugs

Xiaoli Cui
Zhou Yao
Tianyu Zhao
Jiahui Guo
Jipeng Ding
Siwei Zhang
Zuowen Liang
Zhengren Wei
Alexis Zoa
Yuantong Tian

Frontiers in Oncology

doi 10.3389/fonc.2022.1069033

2,458 views
4 citations

Original Research

Published on 15 Dec 2022

MALDI-TOF-MS for rapid screening analysis of M-protein in serum

in Pharmacology of Anti-Cancer Drugs

Jie Li
Anping Xu
Weijie Xie
Bowen Li
Cunliang Yan
Yong Xia
Chao Liang
Ling Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.1073479

3,936 views
3 citations

Case Report

Published on 15 Dec 2022

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Emaan Haque
Ibrahim N. Muhsen
Abdullah Esmail
Godsfavour Umoru
Charisma Mylavarapu
Veronica B. Ajewole
Maen Abdelrahim

Frontiers in Oncology

doi 10.3389/fonc.2022.992455

1,890 views
1 citation

Brief Research Report

Published on 12 Dec 2022

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine

in Pharmacology of Anti-Cancer Drugs

Dominique Bollino
J. Preston Claiborne
Kanwal Hameed
Xinrong Ma
Kayla M. Tighe
Brandon Carter-Cooper
Rena G. Lapidus
Erin T. Strovel
Ashkan Emadi

Frontiers in Oncology

doi 10.3389/fonc.2022.1035537

2,694 views
2 citations

Original Research

Published on 09 Dec 2022

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets

in Pharmacology of Anti-Cancer Drugs

Na Xu
Baohong Li
Yong Liu
Cui Yang
Siqi Tang
William C. Cho
Zunnan Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1017041

5,859 views
9 citations

Original Research

Published on 09 Dec 2022

Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development

in Pharmacology of Anti-Cancer Drugs

Zhili Wen
Ke He
Meixiao Zhan
Yong Li
Fei Liu
Xu He
Yanli Wei
Wei Zhao
Yu Zhang
Yaqiang Xue

Frontiers in Oncology

doi 10.3389/fonc.2022.904633

3,044 views
1 citation

Review

Published on 08 Dec 2022

Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices

in Pharmacology of Anti-Cancer Drugs

Pattanaik Smita
Patil Amol Narayan
Kumaravel J
Prakash Gaurav

Frontiers in Oncology

doi 10.3389/fonc.2022.1015200

7,536 views
16 citations

Editorial

Published on 08 Dec 2022

Editorial: Nanomaterials and multimodal tumor therapy

in Pharmacology of Anti-Cancer Drugs

Yongqi Yang
Qiaohui Chen
Yige Qiu
Yiying Wang
Qiong Huang
Kelong Ai

Frontiers in Oncology

doi 10.3389/fonc.2022.1081687

1,382 views
5 citations

Navigation group

Articles

Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27

New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy

Advances in research on the relationship between thymoquinone and pancreatic cancer

The function of natural compounds in important anticancer mechanisms

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies

A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer

siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro

MALDI-TOF-MS for rapid screening analysis of M-protein in serum

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets

Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development

Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices

Editorial: Nanomaterials and multimodal tumor therapy